Fermentation of soy milk via Lactobacillus plantarum improves dysregulated lipid metabolism in rats on a high cholesterol diet

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Kim, Yunhye ^a   Yoon, Sun ^a   Lee, Sun Bok ^a   Han, Hye Won ^a   Oh, Hayoun ^a   Lee, Wu Joo ^a   Lee, Seung Min ^a  

^a Yonsei University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER A1; ADIPONECTIN; ADIPONECTIN RECEPTOR 1; ADIPONECTIN RECEPTOR 2; AGLYCONE; APOENZYME; APOLIPOPROTEIN A1; CARNITINE PALMITOYLTRANSFERASE I; CHOLESTEROL; CYTOCHROME P450 4A1; FAS LIGAND; FATTY ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; ISOFLAVONE; LIPID; LIVER X RECEPTOR ALPHA; LONG CHAIN ACYL COENZYME A DEHYDROGENASE; LOW DENSITY LIPOPROTEIN RECEPTOR; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; LOW EXPRESSION OF LONG CHAIN ACYL COA DEHYDROGENASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 2; UNCOUPLING PROTEIN 3; VERY LOW DENSITY LIPOPROTEIN RECEPTOR;

ADIPOSE TISSUE; ANALYTICAL PARAMETERS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CHOLESTEROL FECAL LEVEL; CHOLESTEROL LIVER LEVEL; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; DISORDERS OF LIPID METABOLISM; FAS GENE; FATTY ACID BLOOD LEVEL; FATTY ACID OXIDATION; FERMENTATION; GENE; GENE EXPRESSION REGULATION; HIGH DENSITY LIPOPROTEIN CHOLESTEROL BLOOD LEVEL; HMGCR GENE; IN VITRO STUDY; INTERMETHOD COMPARISON; LACTOBACILLUS PLANTARUM; LDLR GENE; LIPID BLOOD LEVEL; LIPOGENESIS; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; SCD1 GENE; SOYBEAN MILK; TRIACYLGLYCEROL BLOOD LEVEL; TRIGLYCEROL LIVER LEVEL;

ADENYLATE KINASE; ADIPONECTIN; ADIPOSE TISSUE; ANIMALS; BIOLOGICAL TRANSPORT; CHOLESTEROL; DIET, HIGH-FAT; ENZYME ACTIVATION; FATTY ACIDS; FEEDING BEHAVIOR; FERMENTATION; GENE EXPRESSION REGULATION; ISOFLAVONES; LACTOBACILLUS PLANTARUM; LIPID METABOLISM; LIVER; MALE; MODELS, BIOLOGICAL; OXIDATION-REDUCTION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADIPONECTIN; RNA, MESSENGER; SOY MILK; TRIGLYCERIDES;

EID: 84895820168     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0088231     Document Type: Article

References (33)

1. Khoo KL, Tan H, Liew YM, Deslypere JP, Janus E (2003) Lipids and coronary heart disease in Asia. Atherosclerosis 169: 1-10. (Pubitemid 36833278)
2. Grundy SM (1998) Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome. Am J Cardiol 81: 18B-25B.
3. Spady DK, Woollett LA, Dietschy JM (1993) Regulation of plasma LDL-cholesterol levels by dietary cholesterol and fatty acids. Annu Rev Nutr 13: 355-381. (Pubitemid 23227789)
4. Taku K, Umegaki K, Sato Y, Taki Y, Endoh K, et al. (2007) Soy isoflavones lower serum total and LDL cholesterol in humans: a meta-analysis of 11 randomized controlled trials. Am J Clin Nutrit 85: 1148-1156. (Pubitemid 46557934)
5. Yasutake K, Nakamuta M, Shima Y, Ohyama A, Masuda K, et al. (2009) Nutritional investigation of non-obese patients with non-alcoholic fatty liver disease: the significance of dietary cholesterol. Scand J Gastroenterol 44: 471-477.
6. Lin Y, Meijer GW, Vermeer MA, Trautwein EA (2004) Soy protein enhances the cholesterol-lowering effect of plant sterol esters in cholesterol-fed hamsters. The Journal of nutrition 134: 143-148. (Pubitemid 38057437)
7. Hoie LH, Morgenstern EC, Gruenwald J, Graubaum HJ, Busch R, et al. (2005) A double-blind placebo-controlled clinical trial compares the cholesterol-lowering effects of two different soy protein preparations in hypercholesterolemic subjects. European journal of nutrition 44: 65-71. (Pubitemid 40386143)
8. Anthony MS, Clarkson TB, Hughes CL Jr, Morgan TM, Burke GL (1996) Soybean isoflavones improve cardiovascular risk factors without affecting the reproductive system of peripubertal rhesus monkeys. J Nutr 126: 43-50. (Pubitemid 26030632)
9. Fukui K, Tachibana N, Wanezaki S, Tsuzaki S, Takamatsu K, et al. (2002) Isoflavone-free soy protein prepared by column chromatography reduces plasma cholesterol in rats. Journal of agricultural and food chemistry 50: 5717-5721.
10. Chien HL, Huang HY, Chou CC (2006) Transformation of isoflavone phytoestrogens during the fermentation of soymilk with lactic acid bacteria and bifidobacteria. Food Microbiol 23: 772-778.
11. Izumi T, Piskula MK, Osawa S, Obata A, Tobe K, et al. (2000) Soy isoflavone aglycones are absorbed faster and in higher amounts than their glucosides in humans. J Nutr 130: 1695-1699. (Pubitemid 30451055)
12. Horton JD, Goldstein JL, Brown MS (2002) SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 109: 1125-1131. (Pubitemid 34496588)
13. Joseph SB, Laffitte BA, Patel PH, Watson MA, Matsukuma KE, et al. (2002) Direct and indirect mechanisms for regulation of fatty acid synthase gene expression by liver X receptors. J Biol Chem 277: 11019-11025. (Pubitemid 34952859)
14. Field FJ, Born E, Murthy S, Mathur SN (2001) Regulation of sterol regulatory element-binding proteins by cholesterol flux in CaCo-2 cells. J Lipid Res 42: 1687-1698. (Pubitemid 33020102)
15. Chambers CM, Ness GC (1997) Translational regulation of hepatic HMG-CoA reductase by dietary cholesterol. Biochem Biophys Res Commun 232: 278-281. (Pubitemid 27216202)
16. Ascencio C, Torres N, Isoard-Acosta F, Gomez-Perez FJ, Hernandez-Pando R, et al. (2004) Soy protein affects serum insulin and hepatic SREBP-1 mRNA and reduces fatty liver in rats. J Nutr 134: 522-529. (Pubitemid 38298490)
17. Kano M, Takayanagi T, Harada K, Sawada S, Ishikawa F (2006) Bioavailability of isoflavones after ingestion of soy beverages in healthy adults. J Nutr 136: 2291-2296. (Pubitemid 44329984)
18. Folch J, Lees M, Sloane Stanley GH (1957) A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 224: 497-509.
19. Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18: 499-502.
20. Haglund O, Luostarinen R, Wallin R, Wibell L, Saldeen T (1991) The effects of fish oil on triglycerides, cholesterol, fibrinogen and malondialdehyde in humans supplemented with vitamin E. J Nutr 121: 165-169.
21. de Wael J, Raaymakers CE, Endeman HJ (1977) Simplified quantitative determination of total fecal bile acids. Clin Chim Acta 79: 465-470. (Pubitemid 8168493)
22. Srivastava RA, Pinkosky SL, Filippov S, Hanselman JC, Cramer CT, et al. (2012) AMP-activated protein kinase: an emerging drug target to regulate imbalances in lipid and carbohydrate metabolism to treat cardio-metabolic diseases. J Lipid Res 53: 2490-2514.
23. Di Cagno R, Mazzacane F, Rizzello CG, Vincentini O, Silano M, et al. (2010) Synthesis of isoflavone aglycones and equol in soy milks fermented by food-related lactic acid bacteria and their effect on human intestinal Caco-2 cells. J Agric Food Chem 58: 10338-10346.
24. Torre-Villalvazo I, Tovar AR, Ramos-Barragan VE, Cerbon-Cervantes MA, Torres N (2008) Soy protein ameliorates metabolic abnormalities in liver and adipose tissue of rats fed a high fat diet. J Nutr 138: 462-468. (Pubitemid 351355241)
25. Carling D, Clarke PR, Zammit VA, Hardie DG (1989) Purification and characterization of the AMP-activated protein kinase. Copurification of acetyl-CoA carboxylase kinase and 3-hydroxy-3-methylglutaryl-CoA reductase kinase activities. Eur J Biochem 186: 129-136. (Pubitemid 20015135)
26. Lawn RM, Wade DP, Garvin MR, Wang X, Schwartz K, et al. (1999) The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway. J Clin Invest 104: R25-31. (Pubitemid 29536327)
27. Schwartz K, Lawn RM, Wade DP (2000) ABC1 gene expression and ApoA-I-mediated cholesterol efflux are regulated by LXR. Biochem Biophys Res Commun 274: 794-802. (Pubitemid 30663699)
28. Tacken PJ, Teusink B, Jong MC, Harats D, Havekes LM, et al. (2000) LDL receptor deficiency unmasks altered VLDL triglyceride metabolism in VLDL receptor transgenic and knockout mice. J Lipid Res 41: 2055-2062. (Pubitemid 32039001)
29. Espirito Santo SM, Rensen PC, Goudriaan JR, Bensadoun A, Bovenschen N, et al. (2005) Triglyceride-rich lipoprotein metabolism in unique VLDL receptor, LDL receptor, and LRP triple-deficient mice. J Lipid Res 46: 1097-1102. (Pubitemid 43109825)
30. Rakhshandehroo M, Knoch B, Muller M, Kersten S (2010) Peroxisome proliferator-activated receptor alpha target genes. PPAR Res 2010.
31. Rossmeisl M, Kovar J, Syrovy I, Flachs P, Bobkova D, et al. (2005) Triglyceride-lowering effect of respiratory uncoupling in white adipose tissue. Obes Res 13: 835-844.
32. Kadowaki T, Yamauchi T (2005) Adiponectin and adiponectin receptors. Endocr Rev 26: 439-451. (Pubitemid 40686653)
33. Lewis GF (1997) Fatty acid regulation of very low density lipoprotein production. Curr Opin Lipidol 8: 146-153.